Johnson & Johnson’s Najat Khan joins BioCentury Washington Editor Steve Usdin in conversation. Khan is the chief data science officer and global head of strategy & operations for R&D at J&J’s Janssen Pharmaceutical Cos., roles in which she is responsible for overseeing the Janssen R&D strategy, pipeline and portfolio optimization and investment, and for integrating data science and digital health end-to-end across the pharmaceutical pipeline.

Alkermes Chairman and CEO Richard Pops joins BioCentury Washington Editor Steve Usdin to discuss how public policy determines the speed and direction of biomedical progress. Pops, who has led the neuroscience and oncology company since 1991, serves on the boards of BIO and PhRMA.